Medication info

Brenosol Injection

Prescription medicationInjections
Ingredient · strength
Glycine›700mg / 100mLL-Glutamic Acid›50mg / 100mLL-Leucine›1290mg / 100mLL-Methionine›440mg / 100mLL-Valine›1400mg / 100mLL-Serine›170mg / 100mLL-Cysteine›35mg / 100mLL-Tyrosine›40mg / 100mLL-Arginine›900mg / 100mLL-Aspartic Acid›100mg / 100mLL-Alanine›710mg / 100mLL-Isoleucine›910mg / 100mLL-Threonine›750mg / 100mLL-Tryptophan›130mg / 100mLL-Phenylalanine›700mg / 100mLL-Proline›500mg / 100mLL-Histidine›500mg / 100mLL-Lysine Acetate›1000mg / 100mL
Manufacturer / importer
SK Chemicals Co., Ltd.
Appearance
A transparent solution that is colorless to pale yellow contained in a polypropylene aqueous injection vial.
Packaging
250mL/box
Approval status
Active

MFDS item code 199401292 · Notified 1994.08.26

Summary

Main use
Improvement of amino acid deficiency (e.g., due to malnutrition or before or after surgery)
Who uses it
Adults · Children
Adult dosage
○ Peripheral intravenous administration - Adults: Usually, 200~400 mL is administered by intravenous drip per dose. - Infusion rate: Based on approximately 120 minutes per 200 mL (approximately 25 drops per minute), it is desirable for about 10 g of total amino acids to be utilized by the body over 60 minutes, ○ Central venous administration Generally, 400~800 mL per day is continuously infused into a central vein in adults using the high-calorie infusion method. In view of the efficiency of amino acid utilization in the body, concomitant administration with a sugar-containing infusion solution is preferred. The dose may be adjusted as appropriate according to age, symptoms, and body weight.
Children's dosage
Infuse slowly in children, older adults, and patients with severe illness.

Ingredients

Manufacturer
SK Chemicals Co., Ltd.

Efficacy & effects

Improvement of amino acid deficiency (e.g., due to malnutrition or before or after surgery)

  • Hypoproteinemia
  • malnutrition
View approved original text

Amino acid supply is used to replenish protein in the body and assist recovery in cases of hypoproteinemia, malnutrition, and before and after surgery.

Dosage and Administration

Adult dosage

○ Peripheral intravenous administration - Adults: Usually, 200~400 mL is administered by intravenous drip per dose. - Infusion rate: Based on approximately 120 minutes per 200 mL (approximately 25 drops per minute), it is desirable for about 10 g of total amino acids to be utilized by the body over 60 minutes, ○ Central venous administration Generally, 400~800 mL per day is continuously infused into a central vein in adults using the high-calorie infusion method. In view of the efficiency of amino acid utilization in the body, concomitant administration with a sugar-containing infusion solution is preferred. The dose may be adjusted as appropriate according to age, symptoms, and body weight.

Children's dosage

Infuse slowly in children, older adults, and patients with severe illness.

Precautions

This medication should always be used according to a doctor's instructions. It should not be used in patients who are in a state of hepatic coma or at risk for it. Patients with severe kidney dysfunction or high blood nitrogen levels should also not receive this medication. Patients with nitrogen metabolism issues, severe heart failure, and pulmonary edema should avoid using this medication. Patients with very low or absent urine output should also not receive it. Patients with abnormally high blood sodium or chloride levels should be cautious due to potential issues caused by the ions included in this medication. Patients in a state of severe acidosis, those with congestive heart failure, edema due to sodium retention, and those with hyperkalemia should use this medication cautiously. Special caution is needed when administering to patients with impaired liver or kidney function. This medication contains sodium bisulfite, which can cause severe allergic reactions in individuals allergic to sulfites, particularly asthmatics, so care should be taken. If a rash or other hypersensitivity reactions occur while using this medication, administration should be stopped immediately. Symptoms like nausea, vomiting, chest discomfort, palpitations, and increased blood pressure may occur. Rapid administration in large volumes can lead to acidosis, so caution is advised. Serious side effects like chills, fever, headache, and difficulty breathing may rarely occur. Metabolic abnormalities can lead to increased blood sugar, electrolyte imbalances, and vitamin deficiencies, especially in patients with weakened liver or kidney function who need to have their condition checked frequently with blood tests. Electrolyte balance should be well monitored when administering large amounts of this medication or using it in conjunction with electrolyte-containing solutions. Excess dosing may lead to metabolic alkalosis, so this should be monitored. Patients with heart, lung, or kidney diseases should control the speed and amount of administration to prevent complications from fluid overload. Diabetic patients should measure their blood sugar frequently while using this medication. This medication may reduce the efficacy when used with certain antibiotics; therefore, consult a doctor before co-administration. Pregnant women should use this medication only under a doctor's judgment since its safety has not been established. Children may have immature liver function, so it should be administered in lower concentrations and blood ammonia levels should be checked frequently. Elderly patients may have decreased physiological function; therefore, administration speed should be slower and dosages adjusted. This medication contains electrolytes, and rapid infusion can result in chills or vomiting; thus, it should be slowly administered intravenously. During the preparation and management of infusion solutions, strict aseptic techniques should be maintained to reduce infection risks. If the solution is discolored or cloudy, do not use it, and adhere to specified storage temperatures and durations. Before use, carefully check the condition of the container, and do not administer if it is damaged.

Side effects

  • Rash
  • nausea
  • vomiting
  • chest discomfort
  • palpitations
  • rapid heartbeat
  • elevated blood pressure
  • acidosis
  • chills
  • fever
Show 26 more
  • headache
  • dyspnea
  • respiratory arrest
  • shock
  • bronchospasm
  • urinary tract spasm
  • metabolic acidosis
  • hypophosphatemia
  • alkalosis
  • hyperglycemia
  • diabetes
  • osmotic diuresis
  • dehydration
  • rebound hypoglycemia
  • elevated liver enzymes
  • vitamin deficiency
  • vitamin excess
  • electrolyte imbalance
  • pediatric hyperammonemia
  • elevated BUN
  • serum amino acid imbalance
  • metabolic alkalosis
  • systemic nitrogen retention
  • hyperammonemia
  • sensory loss
  • coma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and moisture exposure. The recommended storage temperature is between 1 and 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

A transparent solution that is colorless to pale yellow contained in a polypropylene aqueous injection vial.

Package unit

250mL/box

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.